期刊文献+

乳腺癌组织中多药耐药基因产物的表达及其相互关系 被引量:5

Expression of multidrug resistance gene production in breast cancer tissue
下载PDF
导出
摘要 目的 探讨多药耐药 (MDR)基因产物在乳腺癌组织中的表达及其相互关系。方法 应用免疫组织化学方法 ,检测6 9例乳腺癌组织中MDR基因产物 (P gp、GST π、TOPOⅡ )。结果 乳腺癌组织中以P gp和GST π表达为主 ,其表达率分别为88 4 1%和 79 71% ,二者均明显高于TOPOⅡ表达率 5 7 97% (P <0 0 1) ;2种MDR基因产物共表达率为 33 33% ,3种MDR基因产物共表达率为 5 5 0 7% ,均明显高于单独表达率 11 5 9% (P <0 0 1) ;GST π和TOPOⅡ的表达均同时伴有P gp的表达 ,在P gp为阴性情况下 ,没有发现GST π和TOPOⅡ的单独表达和共表达现象。P gp和GST π的表达呈显著正相关 (P <0 0 1) ;P gp和TOPOⅡ的表达呈明显负相关 (P <0 0 5 ) ;GST π和TOPOⅡ的表达呈明显负相关 (P <0 0 5 )。结论 P gp、GST π、TOPOⅡ在乳腺癌组织中表达对肿瘤耐药起重要作用 ,单基因和多基因协同作用 ,以多基因共表达为主。 Objective To explore expression of multidrug resistance(MDR) gene production in breast cancer tissue.Methods A total of 69 case of paraffin embedded breast cancer tissue was stained immunohistochemically for P gp?GST π?TOPOⅡ.Results The positive expression of P gp and GST π separately were 88.41% and 79.71%, which were much higher than the positive expression of TOPOⅡ 57.97% in breast tissue;Among them, the coexpression rate of only 2 MDR gene production and only 2 or 3 MDR gene production was each 33.33% and 88.40%, which exceeded apparently more than individal expression rate 11.59%; The positive expression of GST π and TOPOⅡ often accompanied the expression of P gp;If the expression of P gp was negative, there was no the coexpression of GST π and TOPOⅡ.P gp significantly positively correlated with GST π;P gp negatively related to TOPOⅡ;GST π had obviously negative correlation with TOPOⅡ.Conclusion The expression of P gp?GST π?TOPOⅡ in breast cancer tissue made it important to influence tumor resistance,signal cooperated with many genes,but the coexpression of many gene mostly.
出处 《重庆医学》 CAS CSCD 2002年第11期1068-1069,共2页 Chongqing medicine
关键词 乳腺癌组织 多药耐药 P-糖蛋白 谷胱甘肽转移酶Π DNA拓扑异构酶Ⅱ breast cancer multidrug resistance P glycoprotein glutathione s transferase π TopoisomeraseⅡ
  • 相关文献

参考文献6

  • 1[1]Chung HC, Rha SY, Kim JH, et al. P-glycoprotein:the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer[J].Breast Cancer Res Treat,1997,42:65. 被引量:1
  • 2[2]Izquierdo MA, Scheffer GL, Flens MJ, et al. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs[J].Cytotechnology,1996,19:191. 被引量:1
  • 3[3]Bellamy CO, Harrison DJ. Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast[J].Br J Cancer,1994,69:183. 被引量:1
  • 4[4]Hosking LK, Whelan RD, Shellard SA, et al. Multiple mechanisms of resistance in a series of human testicular teratomacell lines selected for increasing resistance to etoposide[J].Int J Cancer,1994,57:259. 被引量:1
  • 5[5]Vanhoefer U, Yin MB, Harstrick A, et al. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)N-nitrosourea associated with inhibition of multidrug resistance protein(MRP) function[J].Biochenm Pharmacol,1997,53:801. 被引量:1
  • 6[6]Szakas G, Jakab K, Antal F, et al. Diagnostics of multidrug resistance in cancer[J].Pathol Oncol Res,1998,4:251. 被引量:1

同被引文献38

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部